The Traderszone Network

MONTRÉAL, Nov. 30, 2021 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order (“MCTO”), announced on November 1, 2021, in respect of the audited annual financial statements and corresponding management’s discussion and analysis for the year ended June 30, 2021, including the CEO and CFO certifications (collectively, the “Annual Financial Filings”) that were not filed by the required filing deadline of October 28, 2021 (the “Filing Deadline”).

 OCTOPUS TITAN VCT PLC

 OCTOPUS TITAN VCT PLC

OCTOPUS TITAN VCT PLC

OCTOPUS TITAN VCT PLC

Shares of Vir Biotechnology (NASDAQ: VIR) were soaring 18.5% as of 11:08 a.m. ET on Tuesday. The big gain came after H.C. Wainwright analyst Patrick Trucchio boosted his price target on Vir from $135 to $200. He maintained his buy rating on the stock.

Several analysts are bullish about Vir’s prospects. But Wainwright’s Trucchio is the most optimistic by far about the biotech stock. What’s behind his enthusiasm?

Image source: Getty Images.

read more

Earlier this month, the European Crowdfunding Service Providers Regulation (ECSPR) went into effect across the entire European Union. A dramatic step forward in removing internal borders in regards to capital formation, and part of the overall Fintech Action plan, the regulation allows firms in need… Read More